Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Needle-Free Alternative for Hypodermic Injections

By HospiMedica staff writers
Posted on 29 Jan 2008
A no-needle delivery system for mesotherapy drugs allows the administration of soluble salts or other drugs into the body as an alternative to hypodermic injections.

The Mesoderm delivery system utilizes water-based conduits in the skin to allow ionic drug solutions to penetrate, via controlled electroporation-like electrical pulses generated by the system. More...
These pulses increase the skin permeability and allow the transdermal delivery of drugs directly to the target area with an efficiency of transport similar to the hypodermic injections. Both micro-molecules and macromolecules--greater than 800 kDa in mass--such as hyaluronic acids, vitamins, amino acids, heparin, antiinflammatories, and other molecules can be safely and painlessly delivered into the body. Also, by eliminating injections, mesotherapy procedures can be performed by unlicensed staff personnel under the supervision of a physician. Mesoderm, a product of AA Advanced Technology (Chicago, IL, USA), was developed by Microlab Biomedical Company (Pozzuoli, Italy), and has been approved by the U.S. Food and Drug Administration (FDA).

"We broke the Mesotherapy needle. The process is truly painless. There is no swelling, bruising, downtime, or other complications. MesoDerm means immediate results and ultimate comfort for patients,” said Dr. Dr. Aleksy Dobradin, M.D., who together with Dr. Renato Torre developed mesoporation technology at Microlab.

Mesotherapy is a controversial, non-surgical, cosmetic treatment. Mesotherapy employs multiple injections of pharmaceutical and homeopathic medications, plant extracts, vitamins, and other ingredients into the subcutaneous fat. Mesotherapy injections are purported to target adipose fat cells, apparently by inducing rupture and cell death among adipocytes.


Related Links:
AA Advanced Technology
Microlab Biomedical Company

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.